Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Revaccination study of AS03-adjuvanted low-dose influenza vaccine versus Fluarix in adults aged 60 years and older
2006-003815-31Phase 2Completed
- Sponsor
- GSK
- Start
- Aug 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in influenza comparing AS03-adjuvanted low-dose influenza vaccine revaccination with Fluarix revaccination (2 arms). Primary endpoints: Solicited local and general adverse events, Immunogenicity at 21 days and 1 more. Started Aug 2006; status: completed.
02
Drugs
AS03-adjuvanted low-dose influenza vaccineFluarix
03
Conditions
influenza
Beyond the preview
Go deeper on 2006-003815-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003815-31.